Anti-CD46 antibody [EPR4014] - BSA and Azide free
- KO Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Knockout Tested Rabbit Recombinant Monoclonal CD46 antibody. Carrier free. Suitable for ICC/IF, WB, IHC-P and reacts with Human samples.
View Alternative Names
CD46, MCP, MIC10, Membrane cofactor protein, TLX, Trophoblast leukocyte common antigen
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD46 antibody [EPR4014] - BSA and Azide free (AB271871)
ab108307, at 1/500 dilution, staining CD46 in paraffin-embedded Human kidney tissue
Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab108307).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD46 antibody [EPR4014] - BSA and Azide free (AB271871)
ab108307 showing positive staining in Normal uterus tissue.
Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab108307).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD46 antibody [EPR4014] - BSA and Azide free (AB271871)
ab108307 showing positive staining in Breast carcinoma tissue.
Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab108307).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD46 antibody [EPR4014] - BSA and Azide free (AB271871)
ab108307 showing positive staining in Thyroid gland carcinoma tissue.
Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab108307).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD46 antibody [EPR4014] - BSA and Azide free (AB271871)
ab108307 showing positive staining in Colonic adenocarcinoma tissue.
Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab108307).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD46 antibody [EPR4014] - BSA and Azide free (AB271871)
ab108307, at 1/500 dilution, staining CD46 in paraffin-embedded Human tonsil tissue
Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab108307).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD46 antibody [EPR4014] - BSA and Azide free (AB271871)
ab108307 showing positive staining in Normal breast tissue.
Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab108307).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD46 antibody [EPR4014] - BSA and Azide free (AB271871)
ab108307 showing positive staining in Normal placenta tissue.
Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab108307).
- WB
Lab
Western blot - Anti-CD46 antibody [EPR4014] - BSA and Azide free (AB271871)
This data was developed using ab108307, the same antibody clone in a different buffer formulation.
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : CD46 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : K562 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab108307 observed at 50-70 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab108307 was shown to specifically react with when CD46 knockout samples were used. Wild-type and CD46 knockout samples were subjected to SDS-PAGE. ab108307 and ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-CD46 antibody [EPR4014] - BSA and Azide free (ab271871)
Predicted band size: 44 kDa
false
- WB
Lab
Western blot - Anti-CD46 antibody [EPR4014] - BSA and Azide free (AB271871)
Western blot : Anti-CD46 antibody [EPR4014] (ab108307) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab108307 was shown to bind specifically to CD46. A band was observed at 50-75 kDa in wild-type A549 cell lysates with no signal observed at this size in CD46 knockout cell line. To generate this image, wild-type and CD46 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-CD46 antibody [EPR4014] (<a href='/en-us/products/primary-antibodies/cd46-antibody-epr4014-ab108307'>ab108307</a>) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
CD46 knockout A549 cell lysate at 20 µg
Lane 3:
HAP1 cell lysate at 20 µg
Lane 4:
THP-1 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
false
- WB
Unknown
Western blot - Anti-CD46 antibody [EPR4014] - BSA and Azide free (AB271871)
This data was developed using ab108307, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-CD46 antibody [EPR4014] - BSA and Azide free (ab271871) at 1/1000 dilution
Lane 1:
MOLT-4 (Human lymphoblastic leukemia cell line) cell lysate at 10 µg
Lane 2:
Jurkat (Human T cell leukemia cell line from peripheral blood) cell lysate at 10 µg
Lane 3:
HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate at 10 µg
Lane 4:
K562 (Human chronic myelogenous leukemia cell line from bone marrow) cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP conjugate at 1/2000 dilution
Predicted band size: 44 kDa
false
Related conjugates and formulations (2)
-
Anti-CD46 antibody [EPR4014]
-
Anti-CD46 antibody [EPR4014] - Low endotoxin, Azide free
Reactivity data
Product details
ab271871 is the carrier-free version of ab108307.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Beyond its complement regulatory role CD46 acts in immune response modulation and reproduction. It forms a part of a protein complex that involves members such as decay-accelerating factor and complement receptor 1. CD46 also engages in intracellular signaling that affects T cell function and differentiation. In the reproductive context it participates in sperm-oocyte fusion and has a role in trophoblast fusion during placental formation.
Pathways
CD46 integrates into various signaling pathways including the complement and T cell receptor signaling pathways. In the complement pathway CD46 interacts with C3b and factor I promoting cleavage and inactivation of C3b leading to pathway regulation. Involvement in the T cell receptor pathway hints that CD46 signaling protects against overactive immune responses by promoting a switch to a regulatory T cell phenotype which can modulate immunity and prevent autoimmunity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com